OLANZAPINE TEVA ® 15 MG

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

OLANZAPINE 15 MG

Dostupno od:

SALOMON,LEVIN & ELSTEIN LTD

ATC koda:

N05AH03

Farmaceutski oblik:

FILM COATED TABLETS

Administracija rute:

PER OS

Proizveden od:

TEVA OPERATIONS POLAND SP.ZO.O

Terapijska grupa:

OLANZAPINE

Terapijske indikacije:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Datum autorizacije:

2011-04-01